Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TDOCthis companyTeladoc Health, Inc.	$8.99	-6.14×	0.89×	0.49×	10.13×	90.1%	69.5%	-10.4%	-7.9%	-14.5%	-8.3%	23.1%	0.75×	1.76×	-13.34×	2.69×	0.0%	4	-7.07	2	B-
AZTAAzenta, Inc.	$40.14	-23.54×	0.76×	2.21×	21.18×	-69.9%	45.5%	-1.9%	-9.4%	-3.2%	2.1%	2.9%	0.06×	-3.12×	0×	2.98×	0.0%	4	3.8	2	C+
IMNMImmunome, Inc.	$19.48	-8.84×	2.96×	270.32×	-5.86×	-62.3%	57.4%	-3084.8%	-3060.0%	-33.5%	-33.5%	-10.7%	0.01×	3.1×	0×	14.69×	0.0%	2	31.88	2	C+
OMCLOmnicell, Inc.	$37.58	1,015.7×	1.69×	1.76×	20.52×	-34.1%	42.9%	1.0%	0.2%	0.2%	0.1%	4.2%	0.17×	0.08×	2.98×	1.43×	0.0%	7	2.24	3	B+
OMDAOmada Health	$15.05	-71.73×	4.01×	3.54×	-147.27×	-437.4%	65.7%	-4.6%	-4.9%	-5.6%	-5.2%	1.8%	0×	46.71×	-4.72×	3.6×	0.0%	7	8.54	2	C
PGNYProgyny, Inc.	$35.72	37.76×	4.24×	1.7×	20.96×	-29.4%	23.6%	6.6%	4.5%	11.3%	9.6%	8.8%	0.05×	-0.84×	0×	2.73×	0.0%	6	8.5	4	A
Peer median	—	-8.84×	2.96×	2.21×	20.52×	-62.3%	45.5%	-1.9%	-4.9%	-3.2%	0.1%	2.9%	0.05×	0.08×	0×	2.98×	0.0%	6	8.5	2	—